FR05C0042I2 - - Google Patents

Info

Publication number
FR05C0042I2
FR05C0042I2 FR05C0042C FR05C0042C FR05C0042I2 FR 05C0042 I2 FR05C0042 I2 FR 05C0042I2 FR 05C0042 C FR05C0042 C FR 05C0042C FR 05C0042 C FR05C0042 C FR 05C0042C FR 05C0042 I2 FR05C0042 I2 FR 05C0042I2
Authority
FR
France
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
FR05C0042C
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Photocure ASA
Original Assignee
Photocure ASA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26306657&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=FR05C0042(I2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from GBGB9504948.2A external-priority patent/GB9504948D0/en
Priority claimed from GBGB9525822.4A external-priority patent/GB9525822D0/en
Publication of FR05C0042I1 publication Critical patent/FR05C0042I1/fr
Application filed by Photocure ASA filed Critical Photocure ASA
Application granted granted Critical
Publication of FR05C0042I2 publication Critical patent/FR05C0042I2/fr
Active legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00Preparations for testing in vivo
    • A61K49/001Preparation for luminescence or biological staining
    • A61K49/0013Luminescence
    • A61K49/0017Fluorescence in vivo
    • A61K49/0019Fluorescence in vivo characterised by the fluorescent group, e.g. oligomeric, polymeric or dendritic molecules
    • A61K49/0021Fluorescence in vivo characterised by the fluorescent group, e.g. oligomeric, polymeric or dendritic molecules the fluorescent group being a small organic molecule
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K41/00Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
    • A61K41/0057Photodynamic therapy with a photosensitizer, i.e. agent able to produce reactive oxygen species upon exposure to light or radiation, e.g. UV or visible light; photocleavage of nucleic acids with an agent
    • A61K41/00615-aminolevulinic acid-based PDT: 5-ALA-PDT involving porphyrins or precursors of protoporphyrins generated in vivo from 5-ALA
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00Preparations for testing in vivo
    • A61K49/001Preparation for luminescence or biological staining
    • A61K49/0013Luminescence
    • A61K49/0017Fluorescence in vivo
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C229/00Compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • C07C229/02Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton
    • C07C229/04Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated
    • C07C229/22Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated the carbon skeleton being further substituted by oxygen atoms
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10TTECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00Chemistry: analytical and immunological testing
    • Y10T436/14Heterocyclic carbon compound [i.e., O, S, N, Se, Te, as only ring hetero atom]
    • Y10T436/145555Hetero-N

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Dermatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
FR05C0042C 1995-03-10 2005-10-05 Active FR05C0042I2 (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB9504948.2A GB9504948D0 (en) 1995-03-10 1995-03-10 Compounds
GBGB9525822.4A GB9525822D0 (en) 1995-12-18 1995-12-18 Compounds
PCT/GB1996/000553 WO1996028412A1 (fr) 1995-03-10 1996-03-08 Esters de l'acide 5-aminolevulinique en tant qu'agents photosensibilisants en photochimiotherapie

Publications (2)

Publication Number Publication Date
FR05C0042I1 FR05C0042I1 (fr) 2005-02-12
FR05C0042I2 true FR05C0042I2 (fr) 2009-10-30

Family

ID=26306657

Family Applications (1)

Application Number Title Priority Date Filing Date
FR05C0042C Active FR05C0042I2 (fr) 1995-03-10 2005-10-05

Country Status (19)

Country Link
US (1) US6034267A (fr)
EP (1) EP0820432B1 (fr)
JP (1) JP3955093B2 (fr)
KR (1) KR100444007B1 (fr)
CN (1) CN1137087C (fr)
AT (1) ATE202076T1 (fr)
AU (1) AU708076B2 (fr)
CA (1) CA2215069C (fr)
CZ (1) CZ291132B6 (fr)
DE (3) DE122006000051I2 (fr)
ES (1) ES2157424T3 (fr)
FR (1) FR05C0042I2 (fr)
HU (1) HU225148B1 (fr)
LU (1) LU90956I2 (fr)
NL (2) NL300176I1 (fr)
NO (3) NO318379B1 (fr)
NZ (1) NZ303251A (fr)
PT (1) PT820432E (fr)
WO (1) WO1996028412A1 (fr)

Families Citing this family (85)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7530461B2 (en) 1995-03-10 2009-05-12 Photocure Asa Esters of 5-aminolevulinic acid as photosensitizing agents in photochemotherapy
US6492420B2 (en) * 1995-03-10 2002-12-10 Photocure As Esters of 5-aminolevulinic acid as photosensitizing agents in photochemotherapy
US6992107B1 (en) 1995-03-10 2006-01-31 Photocure Asa Esters of 5-aminolevulinic acid and their use as photosensitizing compounds in photochemotherapy
US5895786A (en) * 1996-05-08 1999-04-20 New York Blood Center, Inc. Method for treating viral infections
GB9700396D0 (en) 1997-01-10 1997-02-26 Photocure As Photochemotherapeutic compositions
FR2777782B1 (fr) * 1998-04-22 2001-05-18 Alexandre Marti Solution pour la preparation d'une substance pharmaceutique pour le diagnostic et/ou le traitement de lesions tissulaires
US6223071B1 (en) * 1998-05-01 2001-04-24 Dusa Pharmaceuticals Inc. Illuminator for photodynamic therapy and diagnosis which produces substantially uniform intensity visible light
DE19852245A1 (de) * 1998-11-12 2000-05-18 Asat Ag Applied Science & Tech 5-Aminolävulinsäure-Nanoemulsion
AU782726B2 (en) 1999-07-28 2005-08-25 Commissariat A L'energie Atomique Integration of biochemical protocols in a continuous flow microfluidic device
JP3970492B2 (ja) * 1999-12-14 2007-09-05 コスモ石油株式会社 ピーリング用組成物
DE10003620A1 (de) * 2000-01-28 2001-08-02 Asat Ag Applied Science & Tech 5-Aminolävulinsäure-Formulierung in nichtwässrigen Lösungsmitteln
NO20002428D0 (no) 2000-05-10 2000-05-10 Radiumhospitalets Forskningsst Hudpreparat
US6454790B1 (en) * 2000-07-21 2002-09-24 Ceramoptec Industries, Inc. Treatment for Barrett's syndrome
GB0018527D0 (en) * 2000-07-27 2000-09-13 Photocure Asa Composition
GB0018528D0 (en) * 2000-07-27 2000-09-13 Photocure Asa Compounds
EP1318807A4 (fr) * 2000-08-11 2008-02-20 Ceramoptec Gmbh Onguent photosensibilisant
EP1203944B1 (fr) * 2000-11-06 2006-03-01 Hofstetter, Alfons, Prof.Dr.med. Procédé d'identification de cellules turmorales
BRPI0115794B1 (pt) * 2000-11-29 2015-09-15 Pci Biotech As método para introduzir uma molécula em uma célula, composição farmacêutica, e, uso de uma molécula de transferência associada com um veículo viral e um agente fotossensibilizante ou de uma célula
CN100558903C (zh) 2000-11-29 2009-11-11 Pci生物技术联合股份有限公司 将分子输递进胞质溶胶的光化学内化法
EP1312353A1 (fr) * 2001-11-16 2003-05-21 Ecole Polytechnique Federale De Lausanne (Epfl) Méthode d'épilation
US6723750B2 (en) 2002-03-15 2004-04-20 Allergan, Inc. Photodynamic therapy for pre-melanomas
AU2003230808A1 (en) * 2002-04-05 2003-10-27 Candela Corporation High fluence rate activation of photosensitizers for dermatological applications
DE10301917B4 (de) * 2003-01-17 2007-02-01 Gerhard Saalmann Verwendung von Substanzen der Porphyrinsynthese bei der Phototherapie von Haut- oder Gelenkerkrankungen des Menschen oder von Säugetieren
DE10312659A1 (de) * 2003-03-21 2004-10-07 Universität Regensburg 5-Aminolävulinsäurederivate und ihre Verwendung
US20050209331A1 (en) * 2004-03-22 2005-09-22 Syneron Medical Ltd. Method of treatment of skin
GB0406917D0 (en) * 2004-03-26 2004-04-28 Photocure Asa Compounds
WO2005105022A1 (fr) * 2004-04-28 2005-11-10 Yoshiyasu Ito Fortifiant pour cheveux
JP2005350418A (ja) * 2004-06-11 2005-12-22 Shibuya Kogyo Co Ltd 標的細胞の死滅方法と標的細胞を死滅させるための薬剤及び該薬剤の製造装置
JP5034032B2 (ja) * 2004-09-29 2012-09-26 Sbiファーマ株式会社 腫瘍診断剤
GB0424833D0 (en) * 2004-11-10 2004-12-15 Photocure Asa Method
GB0515550D0 (en) 2005-07-29 2005-09-07 Univ Strathclyde Inactivation of staphylococcus species
US20070225518A1 (en) * 2006-03-22 2007-09-27 Zvi Malik 5-Aminolevulinic acid salts and their use
KR100796450B1 (ko) * 2006-06-29 2008-01-22 전남대학교산학협력단 5-아미노레불린산의 불포화 알킬 에스터 및 약학적으로허용되는 그의 염, 이의 제조방법 및 이의 용도
GB0700580D0 (en) * 2007-01-11 2007-02-21 Photocure Asa Use
JP5098051B2 (ja) 2007-04-05 2012-12-12 Sbiファーマ株式会社 ミトコンドリア障害脳疾患治療剤及び診断剤
AU2014200004B2 (en) * 2007-12-12 2016-10-27 Photocure Asa Use of 5-aminolevulinic acid and derivatives in a solid form for photodynamic treatment and diagnosis
GB0724279D0 (en) * 2007-12-12 2008-01-23 Photocure Asa Use
CA2709274A1 (fr) * 2007-12-14 2009-06-25 Photoderma Sa Nouveaux composes utiles dans des procedes therapeutiques et cosmetiques
CA2715901C (fr) 2008-05-13 2016-05-17 Cosmo Oil Co., Ltd. Agent d'amelioration de la qualite du gazon comprenant de l'acide 5-aminolevulinique ou un derive de celui-ci et un inhibiteur de la biosynthese de la gibberelline
EP2305237B1 (fr) 2008-05-14 2014-04-30 SBI Pharmaceuticals Co., Ltd. Agent thérapeutique pour la stérilité masculine
CA2735426A1 (fr) 2008-09-01 2010-03-04 Swedish Pharma Ab Nouveaux promedicaments a base d'acide 5-aminolevulinique servant a effectuer une therapie photodynamique et un diagnostic photodynamique
CN101745102B (zh) * 2008-12-16 2013-08-07 上海复旦张江生物医药股份有限公司 5-氨基酮戊酸及其衍生物的组合物及其用途
GB0823472D0 (en) * 2008-12-23 2009-01-28 Photocure Asa Product
GB0900461D0 (en) 2009-01-12 2009-02-11 Photocure Asa Photodynamic therapy device
US20100256125A1 (en) * 2009-04-06 2010-10-07 Zila Pharmaceuticals, Inc. Use of improved toluidine blue in photodynamic therapy
CA2974972C (fr) 2009-05-26 2018-12-04 The General Hospital Corporation Procede et appareil pour l'administration dermique d'une substance
ES2573085T3 (es) 2009-06-11 2016-06-06 Photocure Asa Composiciones y productos farmacéuticos semisólidos
BRPI1011650A2 (pt) * 2009-06-11 2016-03-22 Photocure Asa composições sólidas compreendendo ácido 5-aminolevulínico
KR101133770B1 (ko) * 2009-10-27 2012-04-09 주식회사 엔씨테크론 메틸 5-아미노레불리네이트 염산염의 제조방법과 이를 이용한 여드름 및 피부 개선을 위한 피부 외용 화장료 조성물 및 이의 제조방법
EP2542208A1 (fr) 2010-03-01 2013-01-09 Photocure ASA Compositions cosmétiques
EP2394642A1 (fr) 2010-06-10 2011-12-14 Universite De Geneve Formulations de 5-ALA ester et leurs utilisations
WO2011161220A1 (fr) 2010-06-23 2011-12-29 Photocure Asa Préparations hyperosmotiques comprenant de l'acide 5-aminolévulinique ou un de ses dérivés en tant qu'agent photosensibilisant
JP5991970B2 (ja) 2010-07-09 2016-09-14 フォトキュア エイエスエイ 光力学的治療または光力学的診断で使用する乾燥組成物および当該乾燥組成物を含む装置
US9012502B2 (en) 2010-09-14 2015-04-21 Sbi Pharmaceuticals Co., Ltd. Cancer heat therapy-enhancing agent
JP5213293B2 (ja) * 2010-09-30 2013-06-19 コスモ石油株式会社 5−アミノレブリン酸含有固形肥料及びその製造方法
CN103270168A (zh) 2010-12-24 2013-08-28 爱科来株式会社 癌细胞的检测方法
CN102617378B (zh) * 2011-01-26 2016-04-27 上海泺安医药技术有限公司 一种2-(3’-氨基-2’-氧-丙基)丙二酸酯盐及制备
CN102649768B (zh) * 2011-02-25 2016-05-25 上海泺安医药技术有限公司 一种盐酸氨基乙酰丙酸的制备工艺
CN102649767A (zh) * 2011-02-25 2012-08-29 上海泺安医药技术有限公司 一种n-取代氨基乙酰丙酸及其酯制备新工艺
CN102649769B (zh) * 2011-02-25 2015-12-16 上海泺安医药技术有限公司 一种盐酸氨基乙酰丙酸酯的制备工艺
CN102179010B (zh) * 2011-05-27 2013-01-09 吉林大学 脑胶质瘤光动力直接照射治疗装置
WO2013005379A1 (fr) * 2011-07-01 2013-01-10 Sbiファーマ株式会社 Thérapie photodynamique utilisant un agent photosensibilisateur ou de l'acide 5-aminolévulinique
US20140316534A1 (en) 2011-10-14 2014-10-23 Photocure Asa Stent
WO2013053927A1 (fr) 2011-10-14 2013-04-18 Photocure Asa Diagnostic photodynamique d'anomalies du tissu épithélial sous-jacent de l'œsophage au moyen d'un ester de 5-ala
WO2013092505A1 (fr) 2011-12-19 2013-06-27 Photocure Asa Appareil d'irradiation
WO2013092936A2 (fr) 2011-12-20 2013-06-27 Galderma Research & Development Utilisation d'acide 5-aminolévulinique et d'esters, en combinaison avec un dérivé ou un analogue de la vitamine d en photochimiothérapie, et leurs utilisations dans le traitement de l'acné
WO2013111528A1 (fr) * 2012-01-25 2013-08-01 Sbiファーマ株式会社 Agent de diagnostic pour tumeur
WO2013150745A1 (fr) 2012-04-05 2013-10-10 Sbiファーマ株式会社 Dispositif pour la détermination de la métastase du cancer dans un ganglion sentinelle
ES2908080T3 (es) 2012-08-03 2022-04-27 Photocure Asa Compuestos
US20140067024A1 (en) 2012-08-30 2014-03-06 Photocure Asa Dual panel photodynamic therapy lamp
GB201221123D0 (en) 2012-11-23 2013-01-09 Photocure As Device for photodynamic treatment
GB201306369D0 (en) 2013-04-09 2013-05-22 Photocure As Irradiation device
US10716855B2 (en) 2013-12-20 2020-07-21 Galderma Research & Development Pulse photodynamic treatment of photodamaged skin
EP3095464A1 (fr) 2015-05-19 2016-11-23 Universite De Geneve Dérivés de 5-ala et leurs utilisations
GB201522311D0 (en) 2015-12-17 2016-02-03 Photocure Asa Use
RU2745194C2 (ru) 2015-12-17 2021-03-22 ФотоКьюэр АСА Способ фотодинамической терапии (фдт) для рака мочевого пузыря
GB201522309D0 (en) 2015-12-17 2016-02-03 Photocure Asa Use
GB201522398D0 (en) 2015-12-18 2016-02-03 Photocure As Device for photodynamic therapy
CN112010772A (zh) 2016-01-26 2020-12-01 赵鸣 5-氨基酮戊酸及其衍生物的盐化合物和应用
PL3576846T3 (pl) 2017-02-06 2021-07-19 3Skin As Kompozycja przeciwsłoneczna
US11123320B2 (en) 2017-05-31 2021-09-21 Sbi Pharmaceuticals, Co., Ltd. Prophylactic or therapeutic agent for hyperaciive bladder
CN107976508A (zh) * 2017-11-27 2018-05-01 上海百灵医药科技有限公司 一种分析盐酸氨酮戊酸含量和纯度的方法
EP3868372A1 (fr) 2020-02-19 2021-08-25 JLP Health GmbH Combinaison pharmaceutique d'un composé de l'artémisinine et d'un modulateur de la synthèse de l'hème pour le traitement du cancer
CN113651708A (zh) * 2021-08-17 2021-11-16 湖南复瑞生物医药技术有限责任公司 一种5-氨基酮戊酸酯化物的制备及后处理方法
WO2024184417A1 (fr) 2023-03-07 2024-09-12 Photocure Asa Thérapie contre le cancer de la vessie

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2411382C3 (de) * 1974-03-09 1979-09-06 C.H. Boehringer Sohn, 6507 Ingelheim 2-Tetrahydrofurfuryl-6,7-benzomorphane, Verfahren zur Herstellung und deren Verwendung
GB2058077B (en) * 1979-06-08 1983-03-09 Szelke M Enkephalin analogues
CA1236029A (fr) * 1984-05-14 1988-05-03 Edmund Sandborn Solutions pharmaceutiques contenant du dimethylsulfoxyde
JPH0745502B2 (ja) * 1987-11-10 1995-05-17 株式会社トクヤマ 新規化合物及びそれを含む組成物
US5422093A (en) * 1989-07-28 1995-06-06 Queen's University Photochemotherapeutic method using 5-aminolevulinic acid and precursors thereof
US5234940A (en) * 1989-07-28 1993-08-10 Queen's University Photochemotherapeutic method using 5-aminolevulinic acid and precursors thereof
US5079262A (en) * 1989-07-28 1992-01-07 Queen's University At Kingston Method of detection and treatment of malignant and non-malignant lesions utilizing 5-aminolevulinic acid
JP2767318B2 (ja) * 1990-04-11 1998-06-18 株式会社コスモ総合研究所 5―アミノレブリン酸アルキルエステル又はその塩及びその製造方法並びにこれを有効成分とする除草剤
CA2093361C (fr) * 1990-10-05 2002-04-23 Michel Ringuet Derive porphyrine
US5219878A (en) * 1990-10-05 1993-06-15 Queen's University Tetrapyrrole hydroxyalkylamide photochemotherapeutic agents
GB9318841D0 (en) * 1993-09-10 1993-10-27 Res Foundation Of The Norwegia Composition

Also Published As

Publication number Publication date
ATE202076T1 (de) 2001-06-15
NO2005019I2 (no) 2007-04-23
CZ284897A3 (cs) 1998-03-18
NO318379B1 (no) 2005-03-14
DE122006000051I2 (de) 2010-07-08
JP3955093B2 (ja) 2007-08-08
NL300207I2 (nl) 2005-12-01
CN1137087C (zh) 2004-02-04
HUP9800460A2 (hu) 1998-07-28
NO2005024I2 (no) 2007-04-23
NZ303251A (en) 2000-10-27
CA2215069A1 (fr) 1996-09-19
DE69613365T2 (de) 2002-05-02
NO974163D0 (no) 1997-09-09
PT820432E (pt) 2001-09-28
CZ291132B6 (cs) 2002-12-11
JPH11501914A (ja) 1999-02-16
EP0820432A1 (fr) 1998-01-28
WO1996028412A1 (fr) 1996-09-19
ES2157424T3 (es) 2001-08-16
NO2005019I1 (no) 2005-09-26
HU225148B1 (en) 2006-07-28
DE69613365D1 (de) 2001-07-19
AU4950096A (en) 1996-10-02
LU90956I2 (fr) 2002-11-13
DE122006000051I1 (de) 2007-01-04
HUP9800460A3 (en) 1998-08-28
NL300207I1 (nl) 2005-12-01
CN1178521A (zh) 1998-04-08
FR05C0042I1 (fr) 2005-02-12
NO974163L (no) 1997-09-09
AU708076B2 (en) 1999-07-29
KR100444007B1 (ko) 2004-12-03
NL300176I2 (nl) 2005-05-02
NL300176I1 (nl) 2005-05-02
CA2215069C (fr) 2006-09-12
NO2005024I1 (no) 2005-11-14
EP0820432B1 (fr) 2001-06-13
US6034267A (en) 2000-03-07

Similar Documents

Publication Publication Date Title
FR05C0042I2 (fr)
DE69638352D1 (fr)
DE69637714D1 (fr)
IN187860B (fr)
IN186115B (fr)
DK143195A (fr)
IN187131B (fr)
IN188168B (fr)
FR2731335B3 (fr)
CH0741373H1 (fr)
DK0727898T3 (fr)
FR2729815B1 (fr)
IN181822B (fr)
IN182280B (fr)
IN188221B (fr)
IN187853B (fr)
IN187612B (fr)
IN185131B (fr)
DK126096A (fr)
EP0776141A3 (fr)
CN3030542S (fr)
EP0830370A4 (fr)
CN3036648S (fr)
CN3030415S (fr)
EP0766134A3 (fr)